Discover a prescription preservative-free treatment option for your moderate to severe dry eye patients

Symptom Relief Results

The once-daily LACRISERT® delivery system can provide all-day lubrication to protect the eye*

The LACRISERT® insert softens within 1 hour and dissolves in 14 to 18 hours†

*In most patients, one LACRISERT® placed into each eye, once daily, is usually effective in providing all-day symptom relief. Some patients may require twice daily use for optimal results.

†Based on pre-clinical data.

Your moderate to severe dry eye patients may benefit from LACRISERT ®if they:

  • Remain symptomatic in spite of frequent use of artificial tears
  • Are unwilling to frequently apply artificial tears or use ointments or gels
  • Want to continue wearing contact lenses
  • Have undergone LASIK or cataract surgery
  • Suffer from dry eye symptoms secondary to Sjögren’s syndrome

Indications and Usage

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

  • LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.
  • Instructions for inserting and removing LACRISERT® should be carefully followed.
  • If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery.
  • The following adverse reactions have been reported, but were in most instances mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

Click here for full Prescribing Information

© 2018 Bausch & Lomb Incorporated. All rights reserved. LAC.0022.USA.18
CALIFORNIA RESIDENTS: DO NOT SELL MY PERSONAL INFORMATION
see more

Indications and Usage

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

  • LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.

Important Safety Information

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.